...
首页> 外文期刊>Chinese Medical Journal >Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis
【24h】

Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis

机译:通过微卫星分析详细分析了喉鳞状细胞癌中9p13-23杂合性缺失的缺失

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background This study was designed to investigate the hot spots of microsatellite loss of heterozygosity (LOH) on 9p13-23 in laryngeal squamous cell carcinoma and to find out the correlation between the incidence of microsatellite LOH and the clinicopathological parameters. Methods Tumor tissues were obtained from paraffin embedded sections with microdissection. Genomic DNA was extracted from tumor tissues and peripheral blood lymphocytes with the phenol-chloroform. Polymerase chain reaction (PCR) amplification and denaturing gel electrophoresis were carried out in a set of 42 squamous cell carcinoma (SCC) of larynx and corresponding peripheral blood lymphocytes using 13 highly polymorphic microsatellite markers on 9p13-23. The correlation was analyzed between microsatellite LOH at the high frequency on 9p13-23 and clinicopathological parameters in the patients with squamous cell carcinoma of larynx. Results Of the 42 laryngeal cancers, 41 (97. 6%) showed LOH in at least one of the microsatellite markers tested on 9p13-23. The most frequently deleted marker was D9S162 in 17 of the 19 (89. 5%) informative samples. The marker D9S171, which is located on 9p21, had LOH detected in 12 of the 15 informative cases (80. 0%). LOH at the D9S1748 marker (closest to the p16 gene locus) was detected in 18 of the 36 informative cases (50. 0%). Allelic deletion mapping revealed two minimal regions of LOH encompassing markers D9S161-D9S171 on 9p21 and IFNA-D9S162 on 9p22-23. Multiple LOH ( ? 4) on 9p21-23 was found more frequently in the patients under 60 years, with supraglottic SCC or cervical lymph node metastasis than those over 60 years, with glottic SCC or without cervical lymph node metastasis (P < 0. 01 or 0. 01, 0. 05, respectively). On the contrary, there was no correlation between T stages or pathologic classification and the frequency of LOH on 9p21-23 in 42 SCC of Larynx. Conclusions These findings imply the presence of at least two putative tumor suppressor genes on 9p13-23 in laryngeal SCC. Multiple genetic alterations are probably implicated in supraglottic SCC with cervical lymph node metastasis in younger patients.
机译:背景技术本研究旨在调查喉鳞状细胞癌中9p13-23上微卫星杂合性缺失(LOH)的热点,并找出微卫星LOH发生率与临床病理参数之间的相关性。方法从石蜡包埋切片中取肿瘤进行显微解剖。用酚-氯仿从肿瘤组织和外周血淋巴细胞中提取基因组DNA。使用9p13-23上的13个高度多态性微卫星标记,在一组42例喉部鳞状细胞癌(SCC)和相应的外周血淋巴细胞中进行了聚合酶链反应(PCR)扩增和变性凝胶电泳。分析了9p13-23高频微卫星LOH与喉鳞状细胞癌患者的临床病理参数之间的相关性。结果在42例喉癌中,有41例(97. 6%)在9p13-23上测试的至少一种微卫星标记中显示LOH。在19个(89. 5%)信息量样本中的17个中,最经常删除的标记是D9S162。位于9p21上的标记D9S171在15例信息丰富的病例中有12例检测到了LOH(80. 0%)。在36例信息丰富的病例中,有18例(50. 0%)检测到D9S1748标记处的LOH(最接近p16基因位点)。等位基因缺失作图揭示了LOH的两个最小区域,包括9p21上的标记D9S161-D9S171和9p22-23上的IFNA-D9S162。 60岁以下伴声门上SCC或宫颈淋巴结转移的患者中9p21-23的多发LOH(LO?4)比60岁以上伴声门SCC或无颈部淋巴结转移的患者更频繁(P <0。 01或0. 01,0. 05)。相反,T期或病理学分类与喉42 SCC中9p21-23的LOH频率没有相关性。结论这些发现暗示在喉癌中9p13-23上存在至少两个推定的抑癌基因。在年轻患者中,声门上SCC可能伴有多种基因改变并伴有颈部淋巴结转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号